Latest oppositions filed by Tillotts Pharma Ag

This table presents recent patent oppositions filed by Tillotts Pharma Ag against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP2461802Controlled-Release Granular Compositions Containing Mesalazine And Process For The Manufacture ThereofSOFAR SPAFeb 28, 2019
EP2611429Mesalazine Tablet Having Improved DissolutionDISPHAR INTERNATIONAL B.V.Nov 21, 2018
EP2552955Antibodies With Modified Affinity To Fcrn That Promote Antigen ClearanceCHUGAI SEIYAKU KABUSHIKI KAISHAFeb 5, 2018

The following table provides an overview of the latest patents of Tillotts Pharma Ag that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3459528Nov 23, 2022Preparation Of Solid Dosage Forms Comprising Antibodies By Solution/Suspension Layering1